Clusterin overexpression in mice exacerbates diabetic phenotypes but suppresses tumor progression in a mouse melanoma model | Aging
Blood transcriptomes of anti-SARS-CoV2 antibody positive healthy individuals with prior asymptomatic versus clinical infection | medRxiv
University of Athens | Tascmar
Ph.D. Ioannis P Trougakos - Research Lecturer - National Hellenic Research Foundation | LinkedIn
Ioannis P. Trougakos's research works | National and Kapodistrian University of Athens, Athens (uoa) and other places
Third Dose of the BNT162b2 Vaccine Results in Very High Levels of Neutralizing Antibodies Against SARS‐CoV‐2; Results of a Prospective Study in 150 Health Professionals in Greece - Terpos - - American
Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients | BMC Medicine | Full Text
6-bromo-indirubin-3′-oxime (6BIO), a Glycogen synthase kinase-3β inhibitor, activates cytoprotective cellular modules and suppresses cellular senescence-mediated biomolecular damage in human fibroblasts | Scientific Reports
Kinetics of anti‐SARS‐CoV‐2 neutralizing antibodies development after BNT162b2 vaccination in patients with amyloidosis and the impact of therapy - Kastritis - - American Journal of Hematology - Wiley Online Library
Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients,Cell Reports - X-MOL
Frontiers | Blood Transcriptomes of Anti-SARS-CoV-2 Antibody-Positive Healthy Individuals Who Experienced Asymptomatic Versus Clinical Infection | Immunology
SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitors - The Breast
Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications | Journal of Biomedical Science | Full Text
Olive Bioactives: applications and prospects | LE STUDIUM
Amazon.com: Molecular Mechanisms and Models of Aging, Volume 1119 (Annals of the New York Academy of Sciences): 9781573316866: Gonos, Efstathios S., Trougakos, Ioannis P., Chondrogianni, Niki: Books
Ioannis P. Trougakos's research works | National and Kapodistrian University of Athens, Athens (uoa) and other places
Identification of new biomarkers and therapeutic targets for MDR tumours - Stratagem
Greece – Mu.Ta.Lig – COST ACTION CA15135
Ph.D. Ioannis P Trougakos - Research Lecturer - National Hellenic Research Foundation | LinkedIn
Biomedicine Archives - Page 2 of 3 - Neuro-Psychology
